However, there are limited data about the incidence and risk factors of AKI in patients with nonmyeloablative HSCT. We conducted a multicenter, retrospective cohort study of 62 patients from three ...

Here, we present results of a retrospective analysis that compared outcomes among concurrent patients with MDS or tAML prepared for allogeneic HCT with nonmyeloablative or myeloablative conditioning.

来自某机构的研究人员针对非清髓性预处理（nonmyeloablative conditioning）异基因造血干细胞移植（allo-HCT）后患者继发恶性肿瘤（SMNs）的风险展开研究。通过对1720例血液肿瘤患者长达12年的随访发现，SMNs累积发生率达17%，其中非黑色素瘤皮肤癌（n=543）与慢性移植 ...

Nonmyeloablative conditioning followed by a T-cell–depleted hematopoietic stem-cell allograft is a feasible option for patients with chronic granulomatous disease, recurrent life-threatening ...

These results are consistent with a graft-versus-tumor effect. Nonmyeloablative allogeneic stem-cell transplantation can induce sustained regression of metastatic renal-cell carcinoma in patients ...

To allow a donor to be found for nearly all patients, we have used a nonmyeloablative conditioning regimen in conjunction with stem cells from a related donor with one fully mismatched HLA haplotype.

High-Dose Intra-Arterial Cisplatin Boost With Hyperfractionated Radiation Therapy for Advanced Squamous Cell Carcinoma of the Head and Neck PURPOSE: To analyze the impact of pre- and ...

Childs RW. Immunotherapy of Solid Tumors: Nonmyeloablative Allogeneic Stem Cell Transplantation. MedGenMed 4(3), 2002 [formerly published in Medscape Hematology-Oncology eJournal 5(3), 2002 ...

Such "low-intensity" or nonmyeloablative regimens would potentially avoid unnecessary toxicities associated with high-dose conditioning. There are several NST approaches currently being ...

A frontline transplant tandem approach consisting of autologous and nonmyeloablative allogeneic transplantation demonstrated promising OS and PFS among patients with multiple myeloma, according to ...